Partial seizures

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
2 Commercial trials
Drug classes (ATC)
ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1 Phase I (Other): 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Sk Life Science Inc. Commercial
    CENOBAMATE
    2023-506841-52-00 4 countries 2023 n=74
    Ended

Phase I (Other)

1 trial
  • Sk Life Science Inc. Commercial
    CENOBAMATE
    2024-514045-11-00 2 countries 2025 n=4
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Sk Life Science Inc. Commercial 2 Phase I (Other), Phase III 0
New trials by year
2023
1
2025
1
← All indication landscapes